BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1663064)

  • 1. Growth inhibition of Plasmodium falciparum involving carbon centered iron-chelate radical (L., X-)-Fe(III) based on pyridoxal-betaine. A novel type of antimalarials active against chloroquine-resistant parasites.
    Iheanacho EN; Sarel S; Samuni A; Avramovici-Grisaru S; Spira DT
    Free Radic Res Commun; 1991; 15(1):1-10. PubMed ID: 1663064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Plasmodium falciparum growth by a synthetic iron chelator.
    Iheanacho EN; Samuni A; Avramovici-Grisaru S; Sarel S; Spira DT
    Trans R Soc Trop Med Hyg; 1990; 84(2):213-6. PubMed ID: 2202102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of drug-resistant species of Plasmodium falciparum by domain structured N1,N2-derivatized hydrazines: denticity effects, redox switches, and reductant-driven redox-cycling.
    Sarel S; Iheanacho EN; Avramovici-Grisaru S
    Med Chem; 2005 Mar; 1(2):159-71. PubMed ID: 16787311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined effect of iron chelators and classical antimalarials on the in-vitro growth of Plasmodium falciparum.
    van Zyl RL; Havlik I; Monteagudo FS
    J Antimicrob Chemother; 1992 Sep; 30(3):273-8. PubMed ID: 1452491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fe (II)-chelates based on redox-active pyridoxal-betaines as C-centered radicals causing single- and double-strand scissions to DNA.
    Iheanacho EN; Sarel S; Samuni A; Avramovici-Grisaru S; Spira DT
    Free Radic Res Commun; 1991; 11(6):307-15. PubMed ID: 2071028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
    Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
    Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites.
    Walcourt A; Loyevsky M; Lovejoy DB; Gordeuk VR; Richardson DR
    Int J Biochem Cell Biol; 2004 Mar; 36(3):401-7. PubMed ID: 14687919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria pigment and extracellular iron. Possible target for iron chelating agents.
    van Zyl RL; Havlik I; Hempelmann E; MacPhail AP; McNamara L
    Biochem Pharmacol; 1993 Apr; 45(7):1431-6. PubMed ID: 8471067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of novel catecholate siderophores against Plasmodium falciparum.
    Pradines B; Ramiandrasoa F; Basco LK; Bricard L; Kunesch G; Le Bras J
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2094-8. PubMed ID: 8878587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum.
    Pradines B; Tall A; Ramiandrasoa F; Spiegel A; Sokhna C; Fusai T; Mosnier J; Daries W; Trape JF; Kunesch G; Parzy D; Rogier C
    J Antimicrob Chemother; 2006 Jun; 57(6):1093-9. PubMed ID: 16595639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum.
    Pradines B; Rolain JM; Ramiandrasoa F; Fusai T; Mosnier J; Rogier C; Daries W; Baret E; Kunesch G; Le Bras J; Parzy D
    J Antimicrob Chemother; 2002 Aug; 50(2):177-87. PubMed ID: 12161397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial effect of iron chelators.
    Gordeuk VR; Loyevsky M
    Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
    [No Abstract]   [Full Text] [Related]  

  • 13. Mode of action of iron (III) chelators as antimalarials: II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis.
    Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
    Blood; 1994 Aug; 84(3):910-5. PubMed ID: 8043872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro potentiation of antibiotic activities by a catecholate iron chelator against chloroquine-resistant Plasmodium falciparum.
    Pradines B; Ramiandrasoa F; Rolain JM; Rogier C; Mosnier J; Daries W; Fusai T; Kunesch G; Le Bras J; Parzy D
    Antimicrob Agents Chemother; 2002 Jan; 46(1):225-8. PubMed ID: 11751139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity.
    Lytton SD; Mester B; Dayan I; Glickstein H; Libman J; Shanzer A; Cabantchik ZI
    Blood; 1993 Jan; 81(1):214-21. PubMed ID: 8417790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that haem iron in the malaria parasite is not needed for the antimalarial effects of artemisinin.
    Parapini S; Basilico N; Mondani M; Olliaro P; Taramelli D; Monti D
    FEBS Lett; 2004 Sep; 575(1-3):91-4. PubMed ID: 15388339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversed siderophores act as antimalarial agents.
    Shanzer A; Libman J; Lytton SD; Glickstein H; Cabantchik ZI
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6585-9. PubMed ID: 1862083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Meierjohann S; Walter RD; Müller S
    Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
    Tsafack A; Golenser J; Libman J; Shanzer A; Cabantchik ZI
    Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reappraisal of the effects of iron and desferrioxamine on the growth of Plasmodium falciparum 'in vitro': the unimportance of serum iron.
    Peto TE; Thompson JL
    Br J Haematol; 1986 Jun; 63(2):273-80. PubMed ID: 3521714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.